PATENT CLAIM ANALYSIS

Application Number: 16066402
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["549", "049000"]

Abstract:
The present invention relates to quinolin-2(1H)-one derivatives polymorph and its process thereof. Formula (I).

Claim (Index 17):
The process according to  claim 16 , wherein solvent is polar aprotic solvent selected from the group comprising of ketones, esters, nitriles, tetrahydrofuran, dimethyl sulfoxide, dimethyl formamide, halogenated hydrocarbons, wherein ketone is selected from the group comprising of acetone, diethyl ketone, methyl ethyl ketone, methyl isobutyl ketone and methyl propyl ketone, cyclobutanone, cyclopentanone, cyclohexanone or mixtures thereof; esters is selected from group comprising of aliphatic esters, aromatic esters; wherein aliphatic esters are selected from group comprising of ethyl acetate, methyl acetate, isopropyl acetate, tert-butyl methyl acetate, ethyl formate or mixtures thereof; nitrile is selected from the group comprising of aliphatic nitriles selected from C 2 -C 8  nitrile; halogenated hydrocarbons selected from methylene dichloride, ethylene dichloride, chloroform, carbon tetrachloride or mixtures thereof. The base is selected from inorganic base selected from the group comprising of ammonium hydroxide, alkali metal hydroxides selected from sodium hydroxide, potassium hydroxide, cesium hydroxide, lithium hydroxide; alkali metal carbonates selected from sodium carbonate, potassium carbonate, cesium carbonate, lithium carbonate; alkaline metal hydrogen carbonates selected from lithium hydrogen carbonate, sodium hydrogen carbonate, potassium bicarbonate; sodium amide, sodium hydride, potassium hydride and alkaline metal alcoholates, selected from sodium methoxide, sodium ethoxide, potassium methoxide, potassium ethoxide; alkaline metals selected form sodium, potassium; organic bases selected from] triethylamine, tripropylamine, pyridine, quinoline, piperidine, imidazole, N-ethyldiisopropylamine, dimethylaminopyridine, trimethylamine, dimethylaniline, N-methylmorpholine, 1,5-diazabicyclo[4.3.0]nonene-5 (DBN), 1,8-diazabicyclo[5.4.0]undecene-7 (DBU), 1,4-diazabicyclo[2.2.2]octane (DABCO).

Metadata:
- Claim Count in Document: 8.0
- Percentile: 94.0
- Lexical Diversity: 1.15789
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14373163', '15764616', '15541568', '13995786', '10553399']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6858401336913875
- 35 USC 102 Novelty (BERT): 0.4999647739435439
- Combined Prediction Score: 0.6672525977166032
- Mean Citation Score: 237.167226
- Max Citation Score: 244.66219
- Similarity Product: 189.06895374764085

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test